<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="jln" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">jln</book-part-id>
      <title-group>
        <title>Jervell and Lange-Nielsen Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonym: JLNS</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tranebj&#x000e6;rg</surname>
            <given-names>Lisbeth</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="jln.Tc.aff1"/>
          <xref ref-type="aff" rid="jln.Tc.aff2"/>
          <email>lisbeth.tranebjaerg@regionh.dk</email>
          <email>tranebjaerg@sund.ku.dk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Samson</surname>
            <given-names>Ricardo A</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="jln.Tc.aff3"/>
          <email>rsamson@childrensheartcenter.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Green</surname>
            <given-names>Glenn Edward</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="jln.Tc.aff4"/>
          <email>gegreen@med.umich.edu</email>
        </contrib>
      </contrib-group>
      <aff id="jln.Tc.aff1">Professor of Medical Genetics and Genetic Audiology<break/>Department of Clinical Genetics<break/>Rigshospitalet/The Kennedy Center</aff>
      <aff id="jln.Tc.aff2">Institute of Clinical Medicine <break/>The Panum Institute<break/>University of Copenhagen<break/>Copenhagen, Denmark</aff>
      <aff id="jln.Tc.aff3">Director of Electrophysiology<break/>Children&#x02019;s Heart Center Nevada<break/>Las Vegas, Nevada</aff>
      <aff id="jln.Tc.aff4">Department of Otolaryngology / Head and Neck Surgery<break/>University of Michigan<break/>Ann Arbor, Michigan</aff>
      <pub-history>
        <date date-type="created">
          <day>29</day>
          <month>7</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>17</day>
          <month>8</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>13</day>
          <month>1</month>
          <year>2003</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="iso-def" document-type="chapter">Isolated Sulfite Oxidase Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="joubert" document-type="chapter">Joubert Syndrome</related-object>
      <abstract id="jln.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &#x0003e;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of <italic toggle="yes">torsade de pointes</italic> ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of JLNS is established in a child with congenital sensorineural deafness, long QT interval, and presence of biallelic pathogenic variants in either <italic toggle="yes">KCNQ1</italic> or <italic toggle="yes">KCNE1</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Cochlear implantation to treat hearing loss; beta-adrenergic blockers for long QT interval (Note: Beta-blocker treatment is only partially effective.); implantable cardioverter defibrillators (ICDs) for those with a history of cardiac arrest and/or failure to respond to other treatments; ensure availability of automated external defibrillators where appropriate; standard treatment for those with iron-deficiency anemia.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Special precautions during anesthesia are necessary because of the increased risk for cardiac arrhythmia.</p>
          <p><italic toggle="yes">Surveillance:</italic> Beta-blocker dose should be regularly assessed for efficacy and adverse effects, with evaluation every three to six months during rapid growth phases; periodic evaluations of ICDs for inappropriate shocks and pocket or lead complications.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Drugs that cause further prolongation of the QT interval; activities known to precipitate syncopal events in persons with long QT syndrome.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Hearing evaluation by standard newborn hearing screening programs and electrocardiograms for at-risk sibs; molecular genetic testing to confirm the diagnosis if the pathogenic variants in an affected family member are known.</p>
          <p><italic toggle="yes">Pregnancy management</italic>: Consideration should be given as to whether a mother who has a fetus affected with JLNS herself has long QT syndrome.</p>
          <p><italic toggle="yes">Other:</italic> Training for family members in cardiopulmonary resuscitation; use of an ID bracelet explaining the diagnosis; notifying local emergency medical services of high-risk persons with JLNS.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>JLNS is inherited in an autosomal recessive manner. Parents of a child with JLNS are usually heterozygotes; rarely, only one parent is heterozygous (i.e., the proband has one inherited and one <italic toggle="yes">de novo</italic> pathogenic variant). Parents may or may not have the long QT syndrome (LQTS) phenotype. At conception, each sib of an affected individual usually has a 25% chance of being affected with JLNS, a 50% chance of being a carrier of a JLNS-causing pathogenic variant and potentially at risk for LQTS, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="jln.Diagnosis">
        <title>Diagnosis</title>
        <sec id="jln.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Jervell and Lange-Nielsen syndrome (JLNS) <bold>should be suspected</bold> in a proband with the following features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Profound congenital sensorineural deafness</p>
            </list-item>
            <list-item>
              <p>Long QTc interval (&#x0003e;500 msec), often manifest as syncope, most often elicited by emotion or exercise. Note: Normal QTc interval in males is &#x0003c;440 msec and in post-pubertal females is &#x0003c;460 msec.</p>
            </list-item>
          </list>
        </sec>
        <sec id="jln.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of JLNS <bold>is</bold>
<bold>established</bold> in a proband with the above suggestive findings. Identification of biallelic pathogenic variants in either <italic toggle="yes">KCNQ1</italic> or <italic toggle="yes">KCNE1</italic> confirms the diagnosis, particularly if clinical features are inconclusive.</p>
          <p>Note: (1) It is not currently known how many children with molecularly confirmed JLNS have a borderline QTc interval (440-500 msec) or a normal QTc interval. (2) Hearing loss commonly occurs in individuals with <related-object link-type="booklink" source-id="gene" document-id="rws" document-type="chapter">long QT syndrome</related-object> (LQTS). The hearing loss may be entirely unrelated to the etiology of the LQTS, particularly if the hearing loss is moderate.</p>
          <p>Molecular genetic testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serial single-gene testing.</bold> Sequence analysis of <italic toggle="yes">KCNQ1</italic> is performed first and followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found. If only one or no <italic toggle="yes">KCNQ1</italic> pathogenic variant is identified, sequence analysis of <italic toggle="yes">KCNE1</italic> should be performed next.</p>
              <p>In countries with <italic toggle="yes">KCNQ1</italic> founder variants (e.g., Norway) <italic toggle="yes">KCNQ1</italic> sequencing should be carried out with knowledge of these variants to ensure they will be detected (see <xref ref-type="sec" rid="jln.Molecular_Genetics">Molecular Genetics</xref>) [<xref ref-type="bibr" rid="jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</xref>, <xref ref-type="bibr" rid="jln.REF.tranebj_rg.2004">Tranebj&#x000e6;rg 2004</xref>, <xref ref-type="bibr" rid="jln.REF.berge.2008.362">Berge et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.siem.2008.261">Siem et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">KCNE1, KCNQ1</italic> and other genes of interest (see <xref ref-type="sec" rid="jln.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, mitochondrial sequencing, and genome sequencing may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="jln.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Jervell and Lange-Nielsen Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_1">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th>
                  <th id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_2">Proportion of JLNS Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup></th>
                  <th headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNE1</italic>
                  </td>
                  <td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;10%&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~100%&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 8</td>
                </tr>
                <tr>
                  <td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">KCNQ1</italic>
                  </td>
                  <td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~90%&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;95%</td>
                  <td headers="hd_h_jln.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_jln.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">1 family&#x000a0;<sup>9,&#x000a0;10</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="jln.TF.1.1">
                <label>1. </label>
                <p>Genes are listed alphabetically.</p>
              </fn>
              <fn id="jln.TF.1.2">
                <label>2. </label>
                <p>See <related-object source-id="gene" document-id="jln" object-id="jln.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="jln.TF.1.3">
                <label>3. </label>
                <p>See <xref ref-type="sec" rid="jln.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="jln.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="jln.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="jln.TF.1.6">
                <label>6. </label>
                <p>In a study of ten families, nine had pathogenic variants in <italic toggle="yes">KCNQ1</italic> [<xref ref-type="bibr" rid="jln.REF.tyson.2000.499">Tyson et al 2000</xref>]. Of 63 families, six (9.5%) had pathogenic variants in <italic toggle="yes">KCNE1</italic> [<xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al 2006</xref>]. None of the individuals of Norwegian ancestry with JLNS have been shown to have <italic toggle="yes">KCNE1</italic> pathogenic variants [<xref ref-type="bibr" rid="jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</xref>, <xref ref-type="bibr" rid="jln.REF.berge.2008.362">Berge et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.siem.2008.261">Siem et al 2008</xref>]. Pathogenic variants have been found in either <italic toggle="yes">KCNQ1</italic> or <italic toggle="yes">KCNE1</italic> in 94% of individuals with clinical JLNS undergoing molecular testing [<xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al 2006</xref>].</p>
              </fn>
              <fn id="jln.TF.1.7">
                <label>7. </label>
                <p>Three variants in <italic toggle="yes">KCNE1</italic>, all detectable by Sanger sequencing, have been associated with JLNS [<xref ref-type="bibr" rid="jln.REF.schulzebahr.1997.267">Schulze-Bahr et al 1997</xref>, <xref ref-type="bibr" rid="jln.REF.tyson.1997.2179">Tyson et al 1997</xref>].</p>
              </fn>
              <fn id="jln.TF.1.8">
                <label>8. </label>
                <p>No deletions or duplications of <italic toggle="yes">KCNE1</italic> have been reported to cause JLNS.</p>
              </fn>
              <fn id="jln.TF.1.9">
                <label>9. </label>
                <p>
                  <xref ref-type="bibr" rid="jln.REF.sung.2014.395">Sung et al [2014]</xref>
                </p>
              </fn>
              <fn id="jln.TF.1.10">
                <label>10. </label>
                <p>Both deletion and duplication of one or more exons of <italic toggle="yes">KCNQ1</italic> are known to cause long QT syndrome [<xref ref-type="bibr" rid="jln.REF.zehelein.2006.35397">Zehelein et al 2006</xref>, <xref ref-type="bibr" rid="jln.REF.eddy.2008.1275">Eddy et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.sung.2014.395">Sung et al 2014</xref>]; their frequency is unknown.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="jln.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="jln.Clinical_Description">
          <title>Clinical Description</title>
          <p>The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright.</p>
          <p><bold>Hearing loss.</bold> All individuals with molecularly confirmed JLNS have profound bilateral congenital sensorineural deafness (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>).</p>
          <p><bold>Long QTc.</bold> Individuals with JLNS have a QTc interval greater than 500 msec (average 550 msec), indicating increased time for ventricular depolarization and repolarization [<xref ref-type="bibr" rid="jln.REF.winbo.2012.1799">Winbo et al 2012</xref>, <xref ref-type="bibr" rid="jln.REF.winbo.2014.22">Winbo et al 2014</xref>]. Abnormal cardiac depolarization and repolarization may result in tachyarrhythmias (including ventricular tachycardia, episodes of <italic toggle="yes">torsade de pointes</italic> ventricular tachycardia, and ventricular fibrillation), which may culminate in syncope or sudden death.</p>
          <p>QTc prolongation in JLNS, particularly when severe, appears to be associated with increased risk for death in infancy (SIDS). In the <xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al [2006]</xref> study of 135 families with JLNS, the QTc was markedly prolonged (557&#x000b1;65 msec); 50% of individuals had cardiac events before age three years, with emotion and exercise being the primary triggers. Although more than half of untreated children with JLNS die before age 15 years, some individuals are reported to have survived several syncopal episodes during adulthood. Note, however, that selection bias for severely affected individuals cannot be excluded: individuals with putative JLNS but no clinical manifestations other than deafness until adulthood (and to age 50 years in one individual) have been described.</p>
          <p><bold>Anemia.</bold> Individuals with <italic toggle="yes">KCNQ1</italic>-related JLNS have an increased incidence of iron deficiency anemia and hypergastrinemia [<xref ref-type="bibr" rid="jln.REF.winbo.2013.325">Winbo et al 2013</xref>]. This may be due to loss of the KCNQ1 potassium channels and reduced gastric acid secretion.</p>
          <p><bold>Other.</bold> The sex ratio among individuals with JLNS is even, but females are at lower risk for cardiac arrest/sudden death [<xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al 2006</xref>]. Vestibular dysfunction was found in 14/14 deaf individuals with JLNS, irrespective of previous cochlear implantation. The proposed mechanism was disruption of the endolymph homeostasis [<xref ref-type="bibr" rid="jln.REF.winbo.2015.7">Winbo &#x00026; Rydberg 2015</xref>]</p>
          <p>Physical examination is unremarkable except for deafness.</p>
          <p><bold>Heterozygotes.</bold> Individuals who are heterozygous for pathogenic variants associated with JLNS usually have normal hearing. In some heterozygotes, QTc prolongation, fainting, and sudden death never occur. In contrast, some individuals heterozygous for pathogenic variants associated with JLNS may have QTc prolongation associated with fainting and death heritable in an autosomal dominant manner. This form of LQTS is called <related-object link-type="booklink" source-id="gene" document-id="rws" document-type="chapter">Romano-Ward syndrome</related-object> (RWS).</p>
          <p><bold>Histopathology of temporal bone.</bold> Histologic examination of a few temporal bones was performed prior to the availability of molecular genetic testing, but not since. In one Norwegian individual with JLNS resulting from homozygosity for the c.572_576del pathogenic variant in <italic toggle="yes">KCNQ1</italic>, histopathologic examination of the temporal bones showed severe atrophy of the stria vascularis and the organ of Corti with absence of cochlear nerve fibers [Tranebj&#x000e6;rg L &#x00026; Merchant SM, unpublished data (2012)].</p>
        </sec>
        <sec id="jln.Phenotype_Correlations_by_Gene">
          <title>Phenotype Correlations by Gene</title>
          <p>Among six asymptomatic individuals reported by <xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al [2006]</xref>, two had biallelic <italic toggle="yes">KCNQ1</italic> pathogenic variants and four had biallelic <italic toggle="yes">KCNE1</italic> pathogenic variants, further confirming the milder presentation of JLNS associated with <italic toggle="yes">KCNE1</italic> pathogenic variants compared to JLNS associated with <italic toggle="yes">KCNQ1</italic> pathogenic variants.</p>
          <p><bold><italic toggle="yes">KCNQ1</italic>.</bold> Individuals with <italic toggle="yes">KCNQ1</italic>-related JLNS have an increased incidence of iron deficiency anemia and hypergastrinemia [<xref ref-type="bibr" rid="jln.REF.winbo.2013.325">Winbo et al 2013</xref>].</p>
        </sec>
        <sec id="jln.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Among 63 individuals who were genotyped, 33% were compound heterozygotes [<xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al 2006</xref>]. No clinical difference was evident between persons with at least one inactivating variant (e.g., insertion/deletion, splice variant, truncation) and those with missense variants.</p>
        </sec>
        <sec id="jln.Nomenclature">
          <title>Nomenclature</title>
          <p>Lange-Nielsen syndrome has also been called cardioauditory syndrome of Jervell and Lange-Nielsen and surdo-cardiac syndrome.</p>
          <p>JLNS is now appreciated to be a true syndrome, in which the cardiac and cochlear pathologies are attributable to a common molecular etiology. Although there are several case reports in the older literature of individuals with long QT syndrome and non-profound hearing loss, in many of these reports it is likely that the hearing loss and prolonged QT interval have different etiologies (see <xref ref-type="sec" rid="jln.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
        </sec>
        <sec id="jln.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence varies depending on the population studied:</p>
          <list list-type="bullet">
            <list-item>
              <p>Norway has an unusually high prevalence of at least one in 200,000 [<xref ref-type="bibr" rid="jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</xref>]. This prevalence stems from four Norwegian founder variants [<xref ref-type="bibr" rid="jln.REF.berge.2008.362">Berge et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.siem.2008.261">Siem et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.winbo.2012.1799">Winbo et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Sweden also has a prevalence of one in 200,000 based on a study of preadolescent children, identifying 19 affected individuals from 13 families. Eight <italic toggle="yes">KCNQ1</italic> pathogenic variants were identified, of which p.Arg518Ter constituted 12/24 alleles [<xref ref-type="bibr" rid="jln.REF.winbo.2012.1799">Winbo et al 2012</xref>]. Founder variants accounted for 83% of pathogenic variants [<xref ref-type="bibr" rid="jln.REF.winbo.2014.22">Winbo et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>In a study of 350 children with congenital deafness in Turkey, one in 175 had JLNS [<xref ref-type="bibr" rid="jln.REF.ocal.1997.401">Ocal et al 1997</xref>].</p>
            </list-item>
            <list-item>
              <p>A particular missense <italic toggle="yes">KCNQ1</italic> variant has been identified in the heterozygous state in autosomal dominant LQTS and in the homozygous state in JLNS in a few individuals from Finland; however, prevalence of JLNS was not increased in Finland [<xref ref-type="bibr" rid="jln.REF.piippo.2001.562">Piippo et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>An overview of worldwide occurrence was published by <xref ref-type="bibr" rid="jln.REF.tranebj_rg.2004">Tranebj&#x000e6;rg [2004]</xref></p>
            </list-item>
          </list>
          <p>These data are the best available; however, diagnostic criteria using a QTc &#x0003e;440 msec in children are likely to include some false positives, perhaps as many as 15%-20% [<xref ref-type="bibr" rid="jln.REF.allan.2001.178">Allan et al 2001</xref>]. The design of the review by <xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al [2006]</xref> did not allow refinement of prevalence estimates.</p>
        </sec>
      </sec>
      <sec id="jln.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Heterozygosity for pathogenic variants in <italic toggle="yes">KCNQ1</italic> and <italic toggle="yes">KCNE1</italic> has been observed in children without hearing loss who have long QT syndrome (LQTS) inherited in an autosomal dominant manner [<xref ref-type="bibr" rid="jln.REF.towbin.2001.574">Towbin et al 2001</xref>] (also called <related-object link-type="booklink" source-id="gene" document-id="rws" document-type="chapter">Romano-Ward syndrome</related-object>) (see <xref ref-type="sec" rid="jln.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
      </sec>
      <sec id="jln.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Deafness and prolonged QTc</bold> with or without long QT syndrome (LQTS) both have multiple etiologies, including genetic and environmental causes. In many individuals with both deafness and prolonged QTc (or LQTS), the deafness and prolonged QTc (or LQTS) have separate etiologies. All of these possibilities must be considered in each affected individual, particularly in the absence of parental consanguinity or an affected sib. The following considerations are relevant in an individual who has both deafness and prolonged QTc:</p>
        <list list-type="bullet">
          <list-item>
            <p>Prior to the availability of molecular genetic testing, the diagnosis of Jervell and Lange-Nielsen syndrome (JLNS) was based on clinical criteria alone. (Romano-Ward syndrome was commonly diagnosed in persons with LQTS and normal hearing.)</p>
          </list-item>
          <list-item>
            <p>Some children with JLNS may be misdiagnosed with epilepsy and incorrectly treated with antiepileptic drugs before the correct diagnosis of JLNS is established [<xref ref-type="bibr" rid="jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</xref>].</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="rws" document-type="chapter"><bold>Long QT syndrome</bold></related-object><bold>.</bold> Long QT multi-gene panels may include testing for a number of the genes related to disorders discussed in this section. Note: The genes involved and methods used vary by laboratory.</p>
        <p><bold>Romano-Ward syndrome.</bold> The term &#x0201c;Romano-Ward syndrome&#x0201d; (RWS) refers to forms of long QT syndrome with a purely cardiac electrophysiologic disorder, inherited in an autosomal dominant manner (LQTS types 1-3, type 5, type 6, and types 9-15). RWS is characterized by QT prolongation and T-wave abnormalities on ECG and the ventricular tachycardia <italic toggle="yes">torsade de pointes</italic> (TdP). The diagnosis of RWS is made on the basis of a prolonged QT interval on ECG, clinical presentation, and family history; or identification of a pathogenic variant in one or more of the 15 genes known to be associated with LQTS (of which <italic toggle="yes">KCNQ1</italic>, <italic toggle="yes">KCNH2</italic>, and <italic toggle="yes">SCN5A</italic> are the most common) in the absence of profound congenital sensorineural deafness (the presence of which is highly suggestive of Jervell and Lange-Nielsen syndrome). Individuals with pathogenic variants in <italic toggle="yes">KCNE1</italic> may also have atrial fibrillation [<xref ref-type="bibr" rid="jln.REF.olesen.2012.24">Olesen et al 2012</xref>]. Diagnostic criteria have been established for the resting ECG QTc value in the absence of specific conditions known to lengthen the QTc interval. For a summary of the genes known to be associated with RWS, see <related-object link-type="booklink" source-id="gene" document-id="rws" document-type="chapter">Long QT Syndrome</related-object>. Only <italic toggle="yes">KCNQ1</italic> and <italic toggle="yes">KCNE1</italic> have been implicated in both RWS and JLNS.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="timothy" document-type="chapter"><bold>Timothy syndrome</bold></related-object> is a multisystem disorder characterized by cardiac, hand/foot, facial, and neurodevelopmental features. Typical cardiac findings include a rate-corrected QT interval &#x0003e;480 msec, functional 2:1 AV block with bradycardia, tachyarrhythmias, and congenital heart defects (patent ductus arteriosus, patent foramen ovale, ventricular septal defect, tetralogy of Fallot, hypertrophic cardiomyopathy).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="acpp" document-type="chapter"><bold>Andersen-Tawil syndrome</bold></related-object> is characterized by a triad of episodic flaccid muscle weakness (i.e., periodic paralysis), ventricular arrhythmias and prolonged QT interval, and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis.</p>
        <p>Acquired causes of QTc interval prolongation include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Electrolyte abnormalities: hypokalemia, hypomagnesemia, hypocalcemia</p>
          </list-item>
          <list-item>
            <p>Malnutrition or liquid protein diet</p>
          </list-item>
          <list-item>
            <p>Drugs: vasodilators, tricyclic antidepressants, organophosphates, antihistamines, phenothiazines, procainamide, disopyramide, quinidine, and many others. For a complete, updated list see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.crediblemeds.org/">www.crediblemeds.org</ext-link> (registration required).</p>
          </list-item>
          <list-item>
            <p>Primary myocardial problems: cardiomyopathy, myocarditis, ischemia</p>
          </list-item>
          <list-item>
            <p>Central nervous or autonomic system injury; subarachnoid hemorrhage; stellate ganglion blockade</p>
          </list-item>
        </list>
        <p><bold>Hearing loss.</bold> The differential diagnosis for hearing loss includes consideration of other forms of syndromic and nonsyndromic disorders, as well as acquired disorders. For more information on hereditary hearing loss, see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>.</p>
        <p>One disorder that should be noted specifically is <related-object link-type="booklink" source-id="gene" document-id="dfnb1" document-type="chapter">DFNB1</related-object>, the most common autosomal recessive form of nonsyndromic hearing loss. DFNB1 is characterized by congenital, non-progressive, mild-to-profound sensorineural hearing impairment. No other associated medical findings are present. Diagnosis of DFNB1 depends on molecular genetic testing to identify biallelic pathogenic variants in <italic toggle="yes">GJB2</italic> (sequence variants as well as variants in upstream <italic toggle="yes">cis</italic>-regulatory elements [<italic toggle="yes">GJB6</italic> deletions] that alter expression of the gap junction beta-2 protein [connexin 26]). JLNS should be suspected in any infant who has profound bilateral sensorineural hearing loss, no identifiable <italic toggle="yes">GJB2</italic> pathogenic variants, and a normal physical examination.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="brugada" document-type="chapter"><bold>Brugada syndrome</bold></related-object> is characterized by cardiac conduction abnormalities (ST-segment abnormalities in leads V1-V3 on ECG and a high risk for ventricular arrhythmias) that can result in sudden death.</p>
        <p><bold>Sudden infant death syndrome (SIDS)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/272120">272120</ext-link>). Data from multicenter studies indicate that 9.5% of infants with SIDS may be heterozygous for functionally significant variants in one of the known LQTS-related genes. Sudden arrhythmic death may thus be an important contributor to SIDS; it is unknown what proportion of infants with SIDS have or would develop profound hearing impairment. Implementation of universal neonatal hearing screening, supplemented with early electrocardiography, may have the potential to identify high-risk children. However, a recent large population study did not find a higher incidence of JLNS in newborns identified with hearing loss by universal screening [<xref ref-type="bibr" rid="jln.REF.chang.2014">Chang et al 2014</xref>].</p>
      </sec>
      <sec id="jln.Management">
        <title>Management</title>
        <sec id="jln.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Jervell and Lange-Nielsen syndrome (JLNS), the following evaluations are recommended if they have not already been completed:</p>
          <list list-type="bullet">
            <list-item>
              <p>Formal audiology evaluation for extent of hearing loss</p>
            </list-item>
            <list-item>
              <p>Cardiac examination including calculation of QTc</p>
            </list-item>
            <list-item>
              <p>A three-generation family history that focuses on cardiac disease, syncope, and hearing ability</p>
            </list-item>
            <list-item>
              <p>Complete blood count to screen for anemia. If anemia is present, screening for iron deficiency is recommended.</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist</p>
            </list-item>
          </list>
        </sec>
        <sec id="jln.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Hearing loss</bold> in JLNS may be treated successfully with cochlear implantation, an intervention that does not interfere with bipolar pacemakers [<xref ref-type="bibr" rid="jln.REF.green.2000.27">Green et al 2000</xref>, <xref ref-type="bibr" rid="jln.REF.chorbachi.2002.213">Chorbachi et al 2002</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>). To date, the cumulative published experience includes approximately 20 individuals with JLNS who have received cochlear implantation. Of note, the diagnosis of JLNS was only verified with molecular genetic testing in four Norwegian individuals, all of whom had pathogenic variants in <italic toggle="yes">KCNQ1.</italic> An increase in sound-related syncopal episodes was noted after cochlear implantation in one child [<xref ref-type="bibr" rid="jln.REF.alaama.2015.74">Al-Aama et al 2015</xref>].</p>
          <p>Note: Although cochlear implantation appears to be safe, special precautions are necessary during anesthesia because of the increased risk for cardiac arrhythmia [<xref ref-type="bibr" rid="jln.REF.daneshi.2008.314">Daneshi et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.siem.2008.261">Siem et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.yanmei.2008.1723">Yanmei et al 2008</xref>]. One affected individual died during a perioperative cardiac arrest [<xref ref-type="bibr" rid="jln.REF.broomfield.2010.163">Broomfield et al 2010</xref>].</p>
          <p><bold>Cardiac issues.</bold> The main goal in management of JLNS is prevention of syncope, cardiac arrest, and sudden death. Note that efficacy of beta-blocker treatment is only partial: 51% of treated individuals had cardiac events and 27% had cardiac arrest or sudden death. Even with additional therapies (e.g., pacemaker, implantable cardioverter/defibrillator, left sympathetic denervation), 18 (56%) of 32 individuals experienced additional symptoms, including sudden death in seven [<xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al 2006</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Administration of beta-adrenergic blockers has been the traditional first-line medical therapy for cardiac events, but more aggressive, immediate treatment may be appropriate. Cardiac events in JLNS frequently occur despite beta blockade [<xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al 2006</xref>]. <xref ref-type="bibr" rid="jln.REF.goldenberg.2006.1161">Goldenberg et al [2006]</xref> demonstrated markedly increased mortality in individuals with JLNS treated exclusively with beta blockers in comparison to individuals with Romano-Ward syndrome. A mortality rate of 35% over five years was observed for individuals receiving beta blockers exclusively; 86% of individuals treated exclusively with beta blockers experienced a cardiac event. The interactions of beta blockers with other medical conditions (e.g., asthma, diabetes mellitus, depression) should also be considered. Propranolol and nadolol have been shown to be more effective than metoprolol in suppressing cardiac events [<xref ref-type="bibr" rid="jln.REF.chockalingam.2012.2092">Chockalingam et al 2012</xref>, <xref ref-type="bibr" rid="jln.REF.winbo.2014.22">Winbo et al 2014</xref>]. A recent consensus statement advocates use of nadolol as the preferred beta blocker for drug therapy of individuals with long QT syndrome [<xref ref-type="bibr" rid="jln.REF.ackerman.2017.e41">Ackerman et al 2017</xref>].</p>
            </list-item>
            <list-item>
              <p>Implantable cardioverter defibrillators (ICDs) should be considered in individuals with a history of cardiac arrest or failure to respond to other treatments [<xref ref-type="bibr" rid="jln.REF.goel.2004.370">Goel et al 2004</xref>]. More recent recommendations have strongly urged ICD placement for high-risk individuals, defined by the following criteria [<xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al 2006</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>QTc interval &#x0003e;550 msec</p>
                </list-item>
                <list-item>
                  <p>Syncope before age five years</p>
                </list-item>
                <list-item>
                  <p>Male gender, age &#x0003e;20 years with <italic toggle="yes">KCNQ1</italic> pathogenic variant</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>The risk for sudden cardiac death appears to be low in individuals younger than age five years, but medical therapy should be administered early in these high-risk individuals and ICD placement considered after age five years [<xref ref-type="bibr" rid="jln.REF.richter.2006.1169">Richter &#x00026; Brugada 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>In certain cases, the availability of automated external defibrillators in the home, workplace, or school may be applicable, as is appropriate CPR training of family members and those who have regular contact with individuals with JLNS.</p>
            </list-item>
            <list-item>
              <p>Left cardiac sympathetic denervation has been effective for some individuals.</p>
            </list-item>
          </list>
          <p><bold>Iron deficiency anemia.</bold> The treatment of iron deficiency anemia should follow standard guidelines.</p>
        </sec>
        <sec id="jln.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>See <xref ref-type="sec" rid="jln.Treatment_of_Manifestations">Treatment of Manifestations</xref> regarding prevention of syncope, cardiac arrest, and sudden death.</p>
        </sec>
        <sec id="jln.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Special precautions during anesthesia are necessary because of the increased risk for cardiac arrhythmia [<xref ref-type="bibr" rid="jln.REF.daneshi.2008.314">Daneshi et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.siem.2008.261">Siem et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.yanmei.2008.1723">Yanmei et al 2008</xref>].</p>
        </sec>
        <sec id="jln.Surveillance">
          <title>Surveillance</title>
          <p>Beta-blocker dose should be regularly assessed for efficacy and adverse effects, and doses altered as needed. Because dose adjustment is especially important in growing children, evaluation is appropriate every three to six months during rapid growth phases.</p>
          <p>Regular, periodic evaluation of implantable cardioverter defibrillators (ICDs) for inappropriate shocks and pocket or lead complications is indicated.</p>
        </sec>
        <sec id="jln.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>The following should be avoided:</p>
          <list list-type="bullet">
            <list-item>
              <p>Drugs that cause further prolongation of the QT interval or provoke <italic toggle="yes">torsade de pointes</italic>; see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.crediblemeds.org/">www.crediblemeds.org</ext-link> for a complete and updated list (registration required).</p>
            </list-item>
            <list-item>
              <p>Triggers for intense or sudden emotion; activities that are known to precipitate syncopal events in individuals with long QT syndrome, including:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Competitive sports</p>
                </list-item>
                <list-item>
                  <p>Amusement park rides</p>
                </list-item>
                <list-item>
                  <p>Frightening movies</p>
                </list-item>
                <list-item>
                  <p>Jumping into cold water</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>A cardiologist should make recommendations for activity restrictions based on the effectiveness of medical intervention.</p>
        </sec>
        <sec id="jln.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate sibs and parents of a proband in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p>
          <list list-type="bullet">
            <list-item>
              <p>If the pathogenic variants in the family are known, molecular genetic testing can be used to clarify the genetic status of at-risk family members.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variants in the family are not known, ECG testing should be undertaken to evaluate for QT prolongation.</p>
            </list-item>
            <list-item>
              <p>Standard newborn screening programs are sufficient to identify hearing loss in children with JLNS.</p>
            </list-item>
          </list>
          <p>Because of the relationship between JLNS and long QT syndrome, ECG should be considered for relatives at risk for JLNS even if they have normal hearing.</p>
          <p>If the JLNS-causing pathogenic variants in an affected family member are known, molecular genetic testing of a relative with congenital profound sensorineural hearing loss is recommended to confirm the diagnosis of JLNS.</p>
          <p>See <xref ref-type="sec" rid="jln.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="jln.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Consideration should be given as to whether a mother who has a fetus affected with JLNS herself has long QT syndrome [<xref ref-type="bibr" rid="jln.REF.seth.2007.1092">Seth et al 2007</xref>].</p>
        </sec>
        <sec id="jln.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="jln.Other">
          <title>Other</title>
          <p>Family members of individuals with JLNS should be trained in cardiopulmonary resuscitation (CPR) as up to 95% of individuals with JLNS have a cardiac event before adulthood [<xref ref-type="bibr" rid="jln.REF.schwartz.2006.783">Schwartz et al 2006</xref>].</p>
          <p>Affected individuals should wear an ID bracelet explaining their diagnosis.</p>
          <p>It is appropriate to notify local emergency medical services (EMS) of high-risk persons, including those with JLNS [<xref ref-type="bibr" rid="jln.REF.hazinski.2004.278">Hazinski et al 2004</xref>].</p>
        </sec>
      </sec>
      <sec id="jln.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="jln.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Jervell and Lange-Nielsen syndrome (JLNS) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="jln.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Parents of a child with JLNS are usually obligate heterozygotes (i.e., carriers of one <italic toggle="yes">KCNQ1</italic> or <italic toggle="yes">KCNE1</italic> pathogenic variant). In rare cases, only one parent is heterozygous and the other pathogenic variant in the proband is <italic toggle="yes">de novo</italic> [<xref ref-type="bibr" rid="jln.REF.schwartz.2000.262">Schwartz et al 2000</xref>].</p>
            </list-item>
            <list-item>
              <p>Parents may or may not have the long QT syndrome (LQTS) phenotype. Studies have documented autosomal dominant inheritance of moderately prolonged QTc intervals in some, but not all, families in which one or more sibs have JLNS [<xref ref-type="bibr" rid="jln.REF.splawski.1997.1562">Splawski et al 1997</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for evaluation of the parents of a child with JLNS include:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Molecular genetic testing if the pathogenic variants have been identified;</p>
                </list-item>
                <list-item>
                  <p>Comprehensive electrocardiographic testing for evidence of QTc prolongation by a physician familiar with LQTS.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>If both parents of the proband are heterozygous for a JLNS-related pathogenic variant (i.e., both of the variants identified in the proband are inherited), the typical risks at conception to each sib are:</p>
              <list list-type="bullet">
                <list-item>
                  <p>A 25% chance of inheriting two pathogenic variants and being affected with JLNS;</p>
                </list-item>
                <list-item>
                  <p>A 50% chance of inheriting one pathogenic variant. A sib who inherits one pathogenic variant would not be expected to have JLNS but is at risk for LQTS if the inherited pathogenic variant is associated with the LQTS phenotype (approximately 67% of JLNS-associated pathogenic variants are also known to also be associated with autosomal dominant LQTS) [<xref ref-type="bibr" rid="jln.REF.alaama.2015.74">Al-Aama et al 2015</xref>];</p>
                </list-item>
                <list-item>
                  <p>A 25% chance of inheriting neither of the pathogenic variants identified in the proband. A sib who inherits neither of the JLNS-related pathogenic variants is not at increased risk for JLNS or, potentially, LQTS.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If only one parent of the proband is heterozygous for a JLNS-related pathogenic variant (i.e., the proband has one inherited and one <italic toggle="yes">de novo</italic> pathogenic variant), sibs are not at increased risk for JLNS but 50% are potentially at risk for LQTS if the inherited pathogenic variant is associated with the LQTS phenotype.</p>
            </list-item>
            <list-item>
              <p>Recommendations for evaluation of sibs of a proband with JLNS include:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Audiology evaluation;</p>
                </list-item>
                <list-item>
                  <p>Electrophysiologic evaluation for evidence of LQTS;</p>
                </list-item>
                <list-item>
                  <p>Molecular genetic testing if the pathogenic variants in the proband are known;</p>
                </list-item>
                <list-item>
                  <p>Comprehensive electrocardiographic testing for evidence of QTc prolongation by a physician familiar with LQTS.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an individual with JLNS inherit one pathogenic variant; thus, 100% of the proband's offspring are potentially at risk for LQTS.</p>
            </list-item>
            <list-item>
              <p>In the event that the reproductive partner of the proband is also heterozygous for a pathogenic variant in the same gene in which two pathogenic variants have been identified in the proband, the risk to offspring of having JLNS is 50%.</p>
            </list-item>
            <list-item>
              <p>Recommendations for evaluation of the offspring of an individual with JLNS include comprehensive electrocardiographic testing for evidence of QTc prolongation by a physician familiar with LQTS.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Sibs of a proband's parents may also be at 50% risk of having a pathogenic variant in <italic toggle="yes">KCNQ1</italic> or <italic toggle="yes">KCNE1</italic> and at potential risk for LQTS.</p>
        </sec>
        <sec id="jln.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">KCNQ1</italic> or <italic toggle="yes">KCNE1</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="jln.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="jln.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>Because prolonged QTc interval in families with JLNS may follow an autosomal dominant inheritance pattern, it is important that family members at risk undergo electrocardiographic testing for evidence of LQTS early in life. Individuals with LQTS are at increased risk for sudden death and thus require cardiologic intervention. The actual risk for LQTS in family members of individuals with JLNS is not known.</p>
          <p>Individuals who are heterozygous for a JLNS-related pathogenic variant have a single pathogenic variant in a gene associated with LQTS that may cause QTc prolongation or LQTS in either a clinically significant or clinically insignificant form. Whether the variant is clinically significant or insignificant, it may be transmitted in a clinically significant fashion to future generations as either autosomal dominant LQTS (i.e., <related-object link-type="booklink" source-id="gene" document-id="rws" document-type="chapter">Romano-Ward syndrome</related-object>) or JLNS, a confusing phenomenon during pedigree evaluation.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are heterozygous, or are at risk of being heterozygous.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="jln.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">KCNQ1</italic> or <italic toggle="yes">KCNE1</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and in families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="jln.Resources">
        <title>Resources</title>
      </sec>
      <sec id="jln.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="jln.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Jervell and Lange-Nielsen syndrome (JLNS) is caused by an aberration in a potassium channel found in the stria vascularis of the cochlea (inner ear) and the heart. Note that a minority of pathogenic variants in <italic toggle="yes">KCNQ1</italic> and <italic toggle="yes">KCNE1</italic> cause JLNS; the majority cause LQTS (see <xref ref-type="sec" rid="jln.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">KCNQ1</italic> and <italic toggle="yes">KCNE1</italic> encode the alpha and beta subunit proteins (K<sub>V</sub>LQT1/minK) for the slow potassium current, I<sub>Ks</sub> of the cochlea and the heart.</p>
            </list-item>
            <list-item>
              <p>When stimulated by sound, potassium from the scala media of the cochlea passes through the apex of the hair cells, depolarizing the hair cells and causing a calcium-channel-induced release of neurotransmitter onto the auditory nerve. Depolarizations of the auditory nerve are sent centrally where they are perceived as sound. The maintenance of high potassium concentration in the endolymphatic fluid of the inner ear is required for normal hearing. The potassium-rich fluid of the scala media is created by the I<sub>Ks</sub> potassium channels (exclusively K<sub>V</sub>LQT1/minK) in the stria vascularis.</p>
            </list-item>
            <list-item>
              <p>Malfunction in these channels in the cochlea causes deafness.</p>
            </list-item>
            <list-item>
              <p>Malfunction in these channels in the heart results in abnormal ventricular electrical activity and LQTS.</p>
            </list-item>
          </list>
          <sec id="jln.KCNQ1">
            <title>
              <italic toggle="yes">KCNQ1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNQ1</italic> consists of 16 exons spanning approximately 400 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="jln" object-id="jln.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Nearly 30 of the more than 500 reported pathogenic variants in <italic toggle="yes">KCNQ1</italic> are associated with JLNS; ten result in frameshift and premature truncation [<xref ref-type="bibr" rid="jln.REF.tyson.2000.499">Tyson et al 2000</xref>, <xref ref-type="bibr" rid="jln.REF.wang.2002.308">Wang et al 2002</xref>, <xref ref-type="bibr" rid="jln.REF.ning.2003.246">Ning et al 2003</xref>, <xref ref-type="bibr" rid="jln.REF.zehelein.2006.35397">Zehelein et al 2006</xref>, <xref ref-type="bibr" rid="jln.REF.bhuiyan.2008.319">Bhuiyan et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.ohno.2008.687">Ohno et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.zhang.2008.24">Zhang et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.baek.2010.1522">Baek et al 2010</xref>, <xref ref-type="bibr" rid="jln.REF.wang.2011.41">Wang et al 2011</xref>, <xref ref-type="bibr" rid="jln.REF.gao.2012.67">Gao et al 2012</xref>]. Both deletion and duplication of one or more exons of <italic toggle="yes">KCNQ1</italic> are known to cause long QT syndrome [<xref ref-type="bibr" rid="jln.REF.zehelein.2006.35397">Zehelein et al 2006</xref>, <xref ref-type="bibr" rid="jln.REF.eddy.2008.1275">Eddy et al 2008</xref>, <xref ref-type="bibr" rid="jln.REF.sung.2014.395">Sung et al 2014</xref>].</p>
            <p>In individuals of Norwegian descent, it is important to confirm that molecular genetic testing includes detection of the most common <italic toggle="yes">KCNQ1</italic> pathogenic variants reported in this population: c.573_577delGCGCT, p.Arg518Ter, and p.Gln530Ter [<xref ref-type="bibr" rid="jln.REF.tranebj_rg.1999.137">Tranebj&#x000e6;rg et al 1999</xref>].</p>
            <table-wrap id="jln.T.kcnq1_pathogenic_variants_discusse" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p><italic toggle="yes">KCNQ1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="justify" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="justify" scope="row" rowspan="1" colspan="1">c.1552C&#x0003e;T</td>
                    <td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg518Ter&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000218.2">NM_000218.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000209.2">NP_000209.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="justify" scope="row" rowspan="1" colspan="1">c.1588C&#x0003e;T</td>
                    <td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln530Ter</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="justify" scope="row" rowspan="1" colspan="1">c.573_577delGCGCT<break/>(572del5 or 575del5)</td>
                    <td headers="hd_h_jln.T.kcnq1_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg192CysfsTer91</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="jln.TF.2.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
                <fn id="jln.TF.2.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="jln.Prevalence">Prevalence</xref>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The gene product is potassium voltage-gated channel subfamily KQT member 1 (also known as voltage-gated potassium channel protein KvLQT1); this alpha subunit has six transmembrane regions and forms a heteromultimer with the protein encoded by <italic toggle="yes">KCNE1</italic> to form the functional channel I<sub>Ks</sub>.</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants in the gene result in premature truncation and inability to form multimers with the protein encoded by <italic toggle="yes">KCNE1</italic> to form the functional channel I<sub>Ks</sub>. In a mouse model, recessive variants may exhibit a dominant-negative effect that is not clinically observed in affected individuals, suggesting post-translational processing effects in vivo [<xref ref-type="bibr" rid="jln.REF.thomas.2007.99">Thomas et al 2007</xref>, <xref ref-type="bibr" rid="jln.REF.hothi.2009.819">Hothi et al 2009</xref>].</p>
          </sec>
          <sec id="jln.KCNE1">
            <title>
              <italic toggle="yes">KCNE1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">KCNE1</italic> consists of three exons spanning approximately 40 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="jln" object-id="jln.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Four pathogenic variants associated with JLNS have been identified in <italic toggle="yes">KCNE1</italic>, all of which are missense. The majority of pathogenic variants in <italic toggle="yes">KCNE1</italic> are associated with <related-object link-type="booklink" source-id="gene" document-id="rws" document-type="chapter">LQTS</related-object>.</p>
            <p><bold>Normal gene product.</bold> Potassium voltage-gated channel subfamily E member 1 (also known as minK potassium channel protein beta subunit) is a protein of 130 amino acids with one transmembrane region. It forms multimers with the protein encoded by <italic toggle="yes">KCNQ1</italic> to form the functional channel I<sub>Ks</sub>.</p>
            <p><bold>Abnormal gene product.</bold> The specific effect of each pathogenic variant differs in the manner in which it impairs potassium channel function.</p>
          </sec>
        </sec>
      </sec>
      <sec id="jln.References">
        <title>References</title>
        <sec id="jln.Published_GuidelinesConsensus_Statem">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="jln.Published_GuidelinesConsensus_Statem.reflist0">
            <ref id="jln.REF1">
              <mixed-citation publication-type="web">American College of Medical Genetics. Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetic evaluation of congenital hearing loss expert panel. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110944/">online</ext-link>. 2002. Accessed 8-5-17.</mixed-citation>
            </ref>
            <ref id="jln.REF2">
              <mixed-citation publication-type="web">American College of Medical Genetics. Statement on universal newborn hearing screening. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.acmg.net/StaticContent/StaticPages/Universal_Hearing.pdf">online</ext-link>. 2000. Accessed 8-5-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="jln.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="jln.Literature_Cited.reflist0">
            <ref id="jln.REF.ackerman.2017.e41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anne Dubin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowey</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linker</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slotwiner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Triedman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hare</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gold</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Beta blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta blockers equivalent?</article-title>
                <source>Heart Rhythm.</source>
                <year>2017</year>
                <volume>14</volume>
                <fpage>e41</fpage>
                <lpage>e44</lpage>
                <pub-id pub-id-type="pmid">27659101</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.alaama.2015.74">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Aama</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Ghamdi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bdier</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>AlQarawi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiman</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Aama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Aata</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhuiyan</surname>
                    <given-names>ZA</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-phenotype analysis of Jervell and Lange-Nielsen syndrome in six families from Saudi Arabia.</article-title>
                <source>Clin Genet.</source>
                <year>2015</year>
                <volume>87</volume>
                <fpage>74</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24372464</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.allan.2001.178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Allan</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palomaki</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neveux</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haddow</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Long QT syndrome in children: the value of the rate corrected QT interval in children who present with fainting.</article-title>
                <source>J Med Screen</source>
                <year>2001</year>
                <volume>8</volume>
                <fpage>178</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11743033</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.baek.2010.1522">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baek</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bae</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noh</surname>
                    <given-names>CI</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Jervell and Lange-Nielsen syndrome: novel compound heterozygous mutations in the KCNQ1 in a Korean family.</article-title>
                <source>J Korean Med Sci.</source>
                <volume>25</volume>
                <fpage>1522</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20890437</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.berge.2008.362">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berge</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haugaa</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fr&#x000fc;h</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anfinsen</surname>
                    <given-names>O-G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gjjesdaj</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siem</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000d8;yen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greve</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rognum</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallerud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kongsg&#x000e5;rd</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amlie</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leren</surname>
                    <given-names>TP</given-names>
                  </name>
                </person-group>
                <article-title>Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers.</article-title>
                <source>Scand J Clin Lab Invest</source>
                <year>2008</year>
                <volume>68</volume>
                <fpage>362</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18752142</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.bhuiyan.2008.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bhuiyan</surname>
                    <given-names>ZA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Momenah</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amin</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Khadra</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alders</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannens</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>An intronic mutation leading to incomplete skipping of exon-2 in KCNQ1 rescues hearing in Jervell and Lange-Nielsen syndrome.</article-title>
                <source>Prog Biophys Mol Biol.</source>
                <volume>98</volume>
                <fpage>319</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">19027783</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.broomfield.2010.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Broomfield</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruce</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>KMJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsden</surname>
                    <given-names>RT</given-names>
                  </name>
                </person-group>
                <article-title>Cochlear impantation in Jervell &#x00026; Lange-Nielsen syndrome: a cautionary report.</article-title>
                <source>Cochlear Implants Int.</source>
                <year>2010</year>
                <volume>11</volume>
                <fpage>163</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21756604</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.chang.2014">
              <mixed-citation publication-type="other">Chang RK, Lan YT, Silka MJ, Morrow H, Kwong A, Smith-Lang J, Wallerstein R, Lin HJ. Genetic variants for long QT syndrome among infants and children from a statewide newborn hearing screening program cohort. J Pediatr. 2014;164:590-5.e1-3.</mixed-citation>
            </ref>
            <ref id="jln.REF.chockalingam.2012.2092">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chockalingam</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girardengo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Heijden</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauer</surname>
                    <given-names>RNW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spazzolini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rordorf</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rydberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clur</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Heuvel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaab</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilde</surname>
                    <given-names>AAM</given-names>
                  </name>
                </person-group>
                <article-title>Not All beta-blockers are equal in the management of long QT syndrome types 1 and 2.</article-title>
                <source>J Am Coll Cardiol</source>
                <year>2012</year>
                <volume>60</volume>
                <fpage>2092</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23083782</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.chorbachi.2002.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chorbachi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raine</surname>
                    <given-names>CH</given-names>
                  </name>
                </person-group>
                <article-title>Cochlear implantation in Jervell and Lange-Nielsen syndrome.</article-title>
                <source>Int J Pediatr Otorhinolaryngol</source>
                <year>2002</year>
                <volume>66</volume>
                <fpage>213</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">12443809</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.daneshi.2008.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Daneshi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghassemi</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassanzadeh</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Cochlear implantation in children with Jervell and Lange-Nielsen syndrpome</article-title>
                <source>J Laryngol Otol</source>
                <year>2008</year>
                <volume>122</volume>
                <fpage>314</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17498328</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.eddy.2008.1275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eddy</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacCormick</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Love</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skinner</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shelling</surname>
                    <given-names>AN</given-names>
                  </name>
                </person-group>
                <article-title>Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome.</article-title>
                <source>Heart Rhythm</source>
                <year>2008</year>
                <volume>5</volume>
                <fpage>1275</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">18774102</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.gao.2012.67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qiu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Genotype-phenotype analysis of three Chinese families with Jervell and Lange-Nielsen syndrome.</article-title>
                <source>J Cardiovasc Dis Res.</source>
                <volume>3</volume>
                <fpage>67</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">22629021</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.goel.2004.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goel</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelech</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dhala</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Implantable cardioverter defibrillator therapy in children with long QT syndrome.</article-title>
                <source>Pediatr Cardiol.</source>
                <volume>25</volume>
                <fpage>370</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14994181</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.goldenberg.2006.1161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome.</article-title>
                <source>J Cardiovasc Electrophysiol</source>
                <year>2006</year>
                <volume>17</volume>
                <fpage>1161</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16911578</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.green.2000.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuh</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maddern</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haymond</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helffrich</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>Cochlear implantation in Jervell and Lange-Nielsen syndrome.</article-title>
                <source>Ann Otol Rhinol Laryngol Suppl</source>
                <year>2000</year>
                <volume>185</volume>
                <fpage>27</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11140992</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.hazinski.2004.278">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hazinski</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markenson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neish</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerardi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hootman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nichol</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taras</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hickey</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connor</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potts</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Jagt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schexnayder</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garson A Jr</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doherty</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>S</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>2004</year>
                <article-title>Response to cardiac arrest and selected life-threatening medical emergencies: the medical emergency response plan for schools: A statement for healthcare providers, policymakers, school administrators, and community leaders.</article-title>
                <source>Circulation.</source>
                <volume>109</volume>
                <fpage>278</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">14707021</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.hothi.2009.819">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hothi</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Killeen</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grace</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Empirical correlation of triggered activity and spatial and temporal re-entrant substrates with arrhythmogenicity in a murine model for Jervell and Lange-Nielsen syndrome.</article-title>
                <source>Pflugers Arch.</source>
                <volume>458</volume>
                <fpage>819</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">19430811</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.ning.2003.246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ning</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Novel compound heterozygous mutations in the KCNQ1 gene associated with autosomal recessive long QT syndrome (Jervell and Lange-Nielsen syndrome).</article-title>
                <source>Ann Noninvasive Electrocardiol</source>
                <year>2003</year>
                <volume>8</volume>
                <fpage>246</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">14510661</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.ocal.1997.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ocal</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imamoglu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atalay</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ercan Tutar</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Prevalence of idiopathic long QT syndrome in children with congenital deafness.</article-title>
                <source>Pediatr Cardiol.</source>
                <volume>18</volume>
                <fpage>401</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9326683</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.ohno.2008.687">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubota</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makiyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuga</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horie</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel mutation associated with Jervell and Lange-Nielsen syndrome in a Japanese family.</article-title>
                <source>Circ J.</source>
                <volume>72</volume>
                <fpage>687</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">18441444</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.olesen.2012.24">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Olesen</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bentzen</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nielsen</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steffensen</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabbari</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauns&#x000f8;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Svendsen</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation.</article-title>
                <source>BMC Med Genet.</source>
                <volume>13</volume>
                <fpage>24</fpage>
                <pub-id pub-id-type="pmid">22471742</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.piippo.2001.562">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piippo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasternack</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paavonen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viitasalo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toivonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kontula</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.</article-title>
                <source>J Am Coll Cardiol</source>
                <year>2001</year>
                <volume>37</volume>
                <fpage>562</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11216980</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.richter.2006.1169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brugada</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Risk-stratifying Jervell and Lange-Nielsen syndrome from clinical data.</article-title>
                <source>J Cardiovasc Electrophysiol</source>
                <year>2006</year>
                <volume>17</volume>
                <fpage>1169</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">16987380</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.schulzebahr.1997.267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schulze-Bahr</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wedekind</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haverkamp</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;rdt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borggrefe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assmann</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somberg</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breithardt</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oberti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funke</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>KCNE1 mutations cause jervell and Lange-Nielsen syndrome.</article-title>
                <source>Nat Genet.</source>
                <year>1997</year>
                <volume>17</volume>
                <fpage>267</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9354783</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.schwartz.2000.262">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumaine</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antzelevitch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stramba-Badiale</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berti</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bloise</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>A molecular link between the sudden infant death syndrome and the long-QT syndrome.</article-title>
                <source>N Engl J Med</source>
                <year>2000</year>
                <volume>343</volume>
                <fpage>262</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10911008</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.schwartz.2006.783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spazzolini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bathen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amlie</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shkolnikova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berul</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitner-Glindzicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toivonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze-Bahr</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denjoy</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome.</article-title>
                <source>Circulation</source>
                <year>2006</year>
                <volume>113</volume>
                <fpage>783</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">16461811</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.seth.2007.1092">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seth</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNitt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhorin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locati</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napolitano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priori</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Long QT syndrome and pregnancy.</article-title>
                <source>J Am Coll Cardiol.</source>
                <year>2007</year>
                <volume>49</volume>
                <fpage>1092</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17349890</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.siem.2008.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siem</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fr&#x000fc;h</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leren</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heimdal</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teig</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Jervell and Lange-Nielsen syndrome in Norwegian children: Aspects around cochlear implantation, hearing, and balance.</article-title>
                <source>Ear Hear</source>
                <year>2008</year>
                <volume>29</volume>
                <fpage>261</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18595190</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.splawski.1997.1562">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Splawski</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timothy</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Molecular basis of the long-QT syndrome associated with deafness.</article-title>
                <source>N Engl J Med</source>
                <year>1997</year>
                <volume>336</volume>
                <fpage>1562</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9164812</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.sung.2014.395">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sung</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bae</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyun</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seong</surname>
                    <given-names>MW</given-names>
                  </name>
                </person-group>
                <article-title>Large deletion in KCNQ1 identified in a family with Jervell and Lange-Nielsen syndrome.</article-title>
                <source>Ann Lab Med.</source>
                <year>2014</year>
                <volume>34</volume>
                <fpage>395</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25187895</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.thomas.2007.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Killeen</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurung</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakim</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balasubramaniam</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goddard</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grace</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5.</article-title>
                <source>J Physiol.</source>
                <volume>578</volume>
                <fpage>99</fpage>
                <lpage>114</lpage>
                <pub-id pub-id-type="pmid">17095567</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.towbin.2001.574">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Genotype and severity of long QT syndrome.</article-title>
                <source>Drug Metab Dispos.</source>
                <year>2001</year>
                <volume>29</volume>
                <fpage>574</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11259355</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.tranebj_rg.2004">
              <mixed-citation publication-type="book">Tranebj&#x000e6;rg L. Jervell and Lange-Nielsen syndrome. In: Willems PJ, ed. <italic toggle="yes">Genetic Hearing Loss</italic>. New York, NY: Marcel Dekker Publications; 2004:117-34.</mixed-citation>
            </ref>
            <ref id="jln.REF.tranebj_rg.1999.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tranebj&#x000e6;rg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bathen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitner-Glindzicz</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Jervell and Lange-Nielsen syndrome: a Norwegian perspective.</article-title>
                <source>Am J Med Genet</source>
                <year>1999</year>
                <volume>89</volume>
                <fpage>137</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">10704188</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.tyson.1997.2179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tyson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wren</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bathen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aslaksen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000f8;rland</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pembrey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhattacharya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitner-Glindzicz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome.</article-title>
                <source>Hum Mol Genet.</source>
                <year>1997</year>
                <volume>6</volume>
                <fpage>2179</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">9328483</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.tyson.2000.499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tyson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebj&#x000e6;rg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McEntagart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiansen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whiteford</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bathen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aslaksen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorland</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pembrey</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitner-Glindzicz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen.</article-title>
                <source>Hum Genet</source>
                <year>2000</year>
                <volume>107</volume>
                <fpage>499</fpage>
                <lpage>503</lpage>
                <pub-id pub-id-type="pmid">11140949</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.wang.2011.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teng</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pu</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Novel compound heterozygous mutations T2C and 1149insT in the KCNQ1 gene cause Jervell and Lange-Nielsen syndrome.</article-title>
                <source>Int J Mol Med.</source>
                <volume>28</volume>
                <fpage>41</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21380488</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.wang.2002.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zareba</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knilans</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowles</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Compound heterozygous mutations in KvLQT1 cause Jervell and Lange-Nielsen syndrome.</article-title>
                <source>Mol Genet Metab</source>
                <year>2002</year>
                <volume>75</volume>
                <fpage>308</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">12051962</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.winbo.2012.1799">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winbo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stattin</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diamant</surname>
                    <given-names>UB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Persson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rydberg</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden.</article-title>
                <source>Europace.</source>
                <year>2012</year>
                <volume>14</volume>
                <fpage>1799</fpage>
                <lpage>806</lpage>
                <pub-id pub-id-type="pmid">22539601</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.winbo.2013.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winbo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandstr&#x000f6;m</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmqvist</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rydberg</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Iron-deficiency anaemia, gastric hyperplasia, and elevated gastrin levels due to potassium channel dysfunction in the Jervell and Lange-Nielsen Syndrome.</article-title>
                <source>Cardiol Young.</source>
                <year>2013</year>
                <volume>23</volume>
                <fpage>325</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">22805636</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.winbo.2014.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winbo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stattin</surname>
                    <given-names>E-L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diamant</surname>
                    <given-names>UB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Persson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rydberg</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Phenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X/KCNQ1 families.</article-title>
                <source>BMC Cardiovasc Disord.</source>
                <year>2014</year>
                <volume>14</volume>
                <fpage>22</fpage>
                <pub-id pub-id-type="pmid">24552659</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.winbo.2015.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winbo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rydberg</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Vestibular dysfunction is a clinical feature of Jervell and Lange-Nielsen Syndrome.</article-title>
                <source>Scand Cardiovasc J</source>
                <year>2015</year>
                <volume>49</volume>
                <fpage>7</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">25471708</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.yanmei.2008.1723">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yanmei</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yagin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haibo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huiqun</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhengnong</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dongzhen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shankai</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Cochlear implantation in patients with Jervell and Lange_Nielsen syndrome, and a review of the literature.</article-title>
                <source>Int J Pediatr Otorhinolaryngol.</source>
                <year>2008</year>
                <volume>72</volume>
                <fpage>1723</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18805595</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.zehelein.2006.35397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zehelein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kathoefer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalil</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmeier</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ulmer</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katus</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Skipping of exon 1 in the KCNQ1 gene causes Jervell and Lange-Nielsen Syndrome.</article-title>
                <source>J Biol Chem</source>
                <year>2006</year>
                <volume>281</volume>
                <fpage>35397</fpage>
                <lpage>403</lpage>
                <pub-id pub-id-type="pmid">16987820</pub-id>
              </element-citation>
            </ref>
            <ref id="jln.REF.zhang.2008.24">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yin</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>QK</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Identification of a novel KCNQ1 mutation associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long QT syndrome in a Chinese family.</article-title>
                <source>BMC Med Genet.</source>
                <volume>9</volume>
                <fpage>24</fpage>
                <pub-id pub-id-type="pmid">18400097</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="jln.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="jln.Suggested_Reading.reflist0">
            <ref id="jln.REF.cave.2011.691">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cave</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aufderheide</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellison</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hazinski</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiratzka</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lurie</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mosesso</surname>
                    <given-names>VN</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Nadkarni</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potts</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samson</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sayre</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schexnayder</surname>
                    <given-names>SM</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Importance and implementation of training in cardiopulmonary resuscitation and automated external defibrillation in schools: a science advisory from the American Heart Association.</article-title>
                <source>Circulation.</source>
                <year>2011</year>
                <volume>123</volume>
                <fpage>691</fpage>
                <lpage>706</lpage>
                <pub-id pub-id-type="pmid">21220728</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="jln.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="jln.Author_History">
          <title>Author History</title>
          <p>Shane M Daley, MD; Mayo Clinic-Scottsdale (2002-2010)Glenn Edward Green, MD (2002-present)Ricardo A Samson, MD (2002-present)Lisbeth Tranebj&#x000e6;rg, MD, PhD (2002-present)</p>
        </sec>
        <sec id="jln.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>17 August 2017 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 November 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 October 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>23 February 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 March 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>29 July 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>13 January 2003 (gg) Revision: Molecular Genetic Testing</p>
            </list-item>
            <list-item>
              <p>29 July 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>8 October 2001 (gg) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
